CDMO: Avid Bioservices Inc P/S Multiple

Symbol and logo of brand Avid Bioservices Inc (CDMO)

Avid Bioservices, Inc. (CDMO) is implementing water recycling and green energy within biomanufacturing. The current P/S multiple on the GURU.Markets daily price chart reflects the valuation trend, where 5.30 describes the current status of the metric. While US trade barriers constrain growth potential, the company attracts skilled technologists and offers comprehensive social packages to retain key personnel.

Avid Bioservices - CDMO P/S Multiple (period 07/04/2022 - 02/16/2025)

Avid Bioservices, Inc. (CDMO) - metric breakdowns and financial figures

- price and consensus price forecast:
Market Chart Avid Bioservices|CDMO - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Avid Bioservices, Inc.|CDMO - Real Price to Acquire Entire Company
- balance sheet equity data:
Net Assets per Single Share Avid Bioservices|CDMO - Book Capitalization|Market Capitalization to Book Value avidbio.com|CDMO - Company Total Assets
- business debt structure and liquidity details:
Debt to Equity Ratio Avid Bioservices, Inc.|CDMO - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Avid Bioservices, Inc.|CDMO - Company Aggregate Debts|Debt to Book Capitalization Ratio Avid Bioservices Inc|CDMO - Company Long-Term Debts|Short-Term Debt Volume Avid Bioservices|Immediate Liquidity avidbio.com
- financial results and valuation multiples details:
CDMO - Company Net Income|Company Profit Forecast Avid Bioservices, Inc.|CDMO - P/E Multiple|Projected Price to Earnings Ratio Avid Bioservices Inc|CDMO - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Avid Bioservices, Inc.|CDMO - Operating profit before deduction of amortization|Earnings per share for the last twelve months Avid Bioservices|CDMO - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months avidbio.com|CDMO - Earnings growth in current year|Expected earnings per share growth for next year Avid Bioservices, Inc.
- issuer revenue and sales details:
CDMO - Revenue and Sales Volume|Company Expected Sales Volume Avid Bioservices Inc.|CDMO - Price-to-Revenue Ratio|Market Cap to Expected Sales Ratio Avid Bioservices, Inc.
General company analysis:Avid Bioservices CDMO
Manufactured products of Avid Bioservices Inc

The P/S multiple determines investment attractiveness by comparing a business's market value to its annual sales volume to identify asset overvaluation. By analyzing the current P/S multiple, an investor assesses the monetization efficiency of the biopharmaceutical ecosystem of Avid Bioservices, Inc. (CDMO), whose role as a critical manufacturing link in the creation of complex cancer drugs fundamentally justifies the company's market value.

Competing companies

Price-to-Revenue Coefficient IQVIA Holdings|P/S Multiple LH (Laboratory Corporation of America)|MEDP - Market Cap to Revenue|ICON - P/S Multiple|CRL - P/S Multiple|EVO (Evotec SE) - Market Cap to Revenue|Fortrea Corp - Market Capitalization-to-Revenue Ratio|LFCR (Lifecore Biomedical Inc.) - P/S Multiple|OmniAb Corp (OABI) - Price-to-Revenue Coefficient|P/S Multiple NOTV|Price-to-Revenue Ratio CTLT (Catalent, Inc.)|P/S Multiple SCPX (Scorpius Holdings Inc.)